PSA

AMT vs. PSA: Which Stock Is the Better Value Option?

Is Public Storage Stock Still Worth Watching After a 19.9% YTD Gain?

Dividend Safety Check: INDS and Industrial REIT Income

Baron Real Estate Fund Q1 2026 Portfolio Activity

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting